Literature DB >> 7236992

Partial agonist behaviour of adenosine 5'-O-(2-thiodiphosphate) on human platelets.

N J Cusack, S M Hourani.   

Abstract

1 The effects of an adenosine diphosphate (ADP) analogue, adenosine 5'-O-(2-thiodiphosphate) (ADP-beta-S), in which a terminal phosphate oxygen has been replaced by sulphur, were studied on human platelets. 2 ADP-beta-S induced platelet aggregation and inhibited prostaglandin E1 (PGE1)-stimulated adenylate cyclase but in both cases was less potent than ADP and did not achieve the same maximal effects. 3 Both actions of ADP could be inhibited by the simultaneous addition of ADP-beta-S (50 microM). 4 Aggregation induced by 11 alpha, 9 alpha-epoxymethano prostaglandin H2 (a stable endoperoxide analogue) was not inhibited by simultaneous addition of ADP-beta-S (50 microM). 5 The behaviour of ADP-beta-S towards human platelets was consistent with it being a partial agonist.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7236992      PMCID: PMC2071680          DOI: 10.1111/j.1476-5381.1981.tb10436.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  11 in total

1.  Effects of photolysable 2-azido analogues of adenosine, AMP and ADP on human platelets.

Authors:  N J Cusack; G V Born
Journal:  Proc R Soc Lond B Biol Sci       Date:  1977-07-20

2.  Effects of adenosine on levels of adenosine cyclic 3',5'-monophosphate in human blood platelets in relation to adenosine incorporation and platelet aggregation.

Authors:  R J Haslam; G M Rosson
Journal:  Mol Pharmacol       Date:  1975-09       Impact factor: 4.436

3.  The effects of ATP on platelets: evidence against the central role of released ADP in primary aggregation.

Authors:  D E Macfarlane; D C Mills
Journal:  Blood       Date:  1975-09       Impact factor: 22.113

4.  Binding of adenosine diphosphate to human blood platelets and to isolated blood platelet membranes.

Authors:  J P Lips; J J Sixma; M E Schiphorst
Journal:  Biochim Biophys Acta       Date:  1980-04-03

5.  Prostaglandin receptors on human platelets. Structure-activity relationships of stimulatory prostaglandins.

Authors:  D E MacIntyre; E W Salzman; J L Gordon
Journal:  Biochem J       Date:  1978-09-15       Impact factor: 3.857

6.  Interactions of the pharmacological receptors of blood platelets with adenylate cyclase.

Authors:  R J Haslam
Journal:  Ser Haematol       Date:  1973

7.  Effects of alpha, beta-methylene-adenosine-5'-diphosphate on blood platelet aggregation.

Authors:  H Horák; P G Barton
Journal:  Biochim Biophys Acta       Date:  1974-12-24

8.  Analogues of adenosine 5'-diphosphate-new platelet aggregators. Influence of purine ring and and phosphate chain substitutions on the platelet-aggregating potency of adenosine 5'-diphosphate.

Authors:  G Gough; M H Maguire; F Penglis
Journal:  Mol Pharmacol       Date:  1972-03       Impact factor: 4.436

9.  Effect of the rapid shape change of platelets on the transmission and scattering of light through plasma.

Authors:  F Michal; G V Born
Journal:  Nat New Biol       Date:  1971-06-16

10.  ADP is a potent inhibitor of human platelet plasma membrane adenylate cyclase.

Authors:  D M Cooper; M Rodbell
Journal:  Nature       Date:  1979-11-29       Impact factor: 49.962

View more
  6 in total

1.  Differential effects of adenine nucleotide analogues on shape change and aggregation induced by adnosine 5-diphosphate (ADP) in human platelets.

Authors:  H S Park; S M Hourani
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

Review 2.  Nomenclature and classification of purinoceptors.

Authors:  B B Fredholm; M P Abbracchio; G Burnstock; J W Daly; T K Harden; K A Jacobson; P Leff; M Williams
Journal:  Pharmacol Rev       Date:  1994-06       Impact factor: 25.468

3.  Effects of analogues of adenine nucleotides on increases in intracellular calcium mediated by P2T-purinoceptors on human blood platelets.

Authors:  D A Hall; S M Hourani
Journal:  Br J Pharmacol       Date:  1993-03       Impact factor: 8.739

4.  Platelet beta-adrenoceptors.

Authors:  R Kerry; M C Scrutton
Journal:  Br J Pharmacol       Date:  1983-07       Impact factor: 8.739

5.  Effects of RP and SP diastereoisomers of adenosine 5'-O-(1-thiodiphosphate) on human platelets.

Authors:  N J Cusack; S M Hourani
Journal:  Br J Pharmacol       Date:  1981-06       Impact factor: 8.739

6.  Strong G-Protein-Mediated Inhibition of Sodium Channels.

Authors:  Glynis B Mattheisen; Timur Tsintsadze; Stephen M Smith
Journal:  Cell Rep       Date:  2018-05-29       Impact factor: 9.423

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.